Literature DB >> 9548660

The epidemiology of pancreatic diseases in Japan.

K Oomi1, M Amano.   

Abstract

We reviewed the trends and death rates of pancreatic cancer and pancreatitis in Japan over the past four decades. It is a disturbing fact that the death rate due to pancreatic cancer is rising, parallel to that of lung cancer and colon cancer and that it is affecting primarily the elderly 65 years and older in both sexes. The cause of this increase is partially attributable to improvements in the diagnosis, changes in life-style, and smoking. The death rate due to chronic and acute pancreatitis has remained constant during the past four decades.

Entities:  

Mesh:

Year:  1998        PMID: 9548660     DOI: 10.1097/00006676-199804000-00005

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  4 in total

1.  LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice.

Authors:  Rene Hennig; Jacinthe Ventura; Ralf Segersvard; Erin Ward; Xian-Zhong Ding; Sambasiva M Rao; Borko D Jovanovic; Takeshi Iwamura; Mark S Talamonti; Richard H Bell; Thomas E Adrian
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

2.  Pancreatic cancer mortality in China (1991-2000).

Authors:  Li Wang; Gong-Huan Yang; Xing-Hua Lu; Zheng-Jing Huang; Hui Li
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

3.  15-lipoxygenase-1 production is lost in pancreatic cancer and overexpression of the gene inhibits tumor cell growth.

Authors:  René Hennig; Timo Kehl; Seema Noor; Xian-Zhong Ding; Sambasiva M Rao; Frank Bergmann; Gerhard Fürstenberger; Markus W Büchler; Helmut Friess; Peter Krieg; Thomas E Adrian
Journal:  Neoplasia       Date:  2007-11       Impact factor: 5.715

4.  BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation.

Authors:  R Hennig; T Osman; I Esposito; N Giese; S M Rao; X-Z Ding; W-G Tong; M W Büchler; T Yokomizo; H Friess; T E Adrian
Journal:  Br J Cancer       Date:  2008-09-09       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.